"IL-2" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonAnti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 tr...
Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial Nature
IL-2 and GLP-1 receptor agonist combination tackles neuroinflammation - Drug Target Review
IL-2 and GLP-1 receptor agonist combination tackles neuroinflammation Drug Target Review
First-in-Class IL-2 Pathway Agonist Advances in AD - Dermatology Times
First-in-Class IL-2 Pathway Agonist Advances in AD Dermatology Times
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, dou...
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC - CancerNetwork
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC CancerNetwork
IL-2 and IL-15 augment HBV therapeutic vaccination and PD1 blockade for functional cure in the AA...
Aulos looks to Phase III for IL-2 mAb in NSCLC and melanoma - Clinical Trials Arena
Aulos looks to Phase III for IL-2 mAb in NSCLC and melanoma Clinical Trials Arena
Nektar says IL-2 pathway agonist rejected by Lilly succeeds in atopic dermatitis trial - FirstWor...
Nektar says IL-2 pathway agonist rejected by Lilly succeeds in atopic dermatitis trial FirstWord Pharma
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals - ...
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals Science | AAAS
[ESMO 2025] GI Innovation’s IL-2 therapy shows tumor response in ICB-resistant cancers - koreabio...
[ESMO 2025] GI Innovation’s IL-2 therapy shows tumor response in ICB-resistant cancers koreabiomed.com
PD-1 + IL-2 power couple: Wake up 'sleepy' T cells to turbo-charge cancer cures - EurekAlert!
PD-1 + IL-2 power couple: Wake up 'sleepy' T cells to turbo-charge cancer cures EurekAlert!
αTIGIT-IL2 achieves tumor regression by promoting tumor-infiltrating regulatory T cell fragility ...
Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC - CancerNetwork
Novel IL-2 Therapy Combo Yields Initial Responses in Nonsquamous NSCLC CancerNetwork
In Silico tool for predicting, designing and scanning IL-2 inducing peptides | Scientific Reports...
In Silico tool for predicting, designing and scanning IL-2 inducing peptides | Scientific Reports Nature
TIM3-blockade synergizes with IL2 in alleviating intra-tumoral CD8+T cell exhaustion | Nature Com...
Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune respons...
Long-acting IL-2 release from pressure-fused biomineral tablets promotes antitumor immune response Nature
Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficac...
An immune competent in vitro model of IL2 induced vascular leakage enables mechanistic insights a...
An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammat...
Biomineral tablets for long-acting IL-2 immunotherapy - Nature
Biomineral tablets for long-acting IL-2 immunotherapy Nature
PD-1 x IL-2 antibody fusions: The next Keytruda competitors? - BioCentury
PD-1 x IL-2 antibody fusions: The next Keytruda competitors? BioCentury
Low-dose interleukin-2 for recurrent early pregnancy loss: a proof-of-concept study - medRxiv
Low-dose interleukin-2 for recurrent early pregnancy loss: a proof-of-concept study medRxiv
Mural risks going to the wall as IL-2 flop triggers 90% staff reduction, hunt for strategic alter...
Mural risks going to the wall as IL-2 flop triggers 90% staff reduction, hunt for strategic alternatives Fierce Biotech
Anti-cancer effect of interleukin-2 fused to flagellin expressed by tumor-targeting Salmonella | ...
Examining the evidence for IL-2 in amyotrophic lateral sclerosis - The Lancet
Examining the evidence for IL-2 in amyotrophic lateral sclerosis The Lancet
Adding low-dose IL-2 to riluzole may improve survival in ALS - ALS News Today
Adding low-dose IL-2 to riluzole may improve survival in ALS ALS News Today
Design of facilitated dissociation enables timing of cytokine signalling - Nature
Design of facilitated dissociation enables timing of cytokine signalling Nature
A higher ratio of IL-2/IL-4 may be an early predictor of acute graft-versus-host disease after al...
Topline atopic dermatitis data showcase IL-2 modulator’s ‘incredibly novel’ mechanism - Healio
Topline atopic dermatitis data showcase IL-2 modulator’s ‘incredibly novel’ mechanism Healio
FDA Clears IND for GL-IL2-138 in Cancer and Beyond - Targeted Oncology
FDA Clears IND for GL-IL2-138 in Cancer and Beyond Targeted Oncology
Reshape the Fates of Treg and CD8+T Cells Through IL-2Rα by Synergizing Divergent Receptor-Biased...
9 biotechs making waves in interleukin therapeutics in 2025 - Labiotech.eu
9 biotechs making waves in interleukin therapeutics in 2025 Labiotech.eu
CD301b+ dendritic cell-derived IL-2 dictates CD4+ T helper cell differentiation | Nature Communic...
Korea. IL-2 Series - Official Pre-Order Trailer - IGN
Mural hits a wall | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Mural hits a wall | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 ove...
Low-dose interleukin-2 added to standard ALS treatment extends patient survival, clinical trial f...
Low-dose interleukin-2 added to standard ALS treatment extends patient survival, clinical trial finds Medical Xpress
BLIMP1 negatively regulates IL-2 signaling in T cells - Science | AAAS
BLIMP1 negatively regulates IL-2 signaling in T cells Science | AAAS
A glimpse into the application of the immunomodulatory effect of IL-2 in systemic lupus erythemat...
Interleukin-2 Inhibitors Clinical Trial Pipeline - GlobeNewswire
Interleukin-2 Inhibitors Clinical Trial Pipeline GlobeNewswire
Coya Therapeutics Announces Results of Investigator-Initiated Study of LD IL-2 and CTLA4-Ig Demon...
Coordinating interleukin-2 encoding circRNA with immunomodulatory lipid nanoparticles to potentia...
Coordinating interleukin-2 encoding circRNA with immunomodulatory lipid nanoparticles to potentiate cancer immunotherapy Science | AAAS
France: budget approved, Lecornu survives censorship - Il Sole 24 ORE
France: budget approved, Lecornu survives censorship Il Sole 24 ORE
Korea. IL-2 Series Releases New Gameplay Trailer - Bleeding Cool News
Korea. IL-2 Series Releases New Gameplay Trailer Bleeding Cool News
New Flight Sim Wants You Broke To Get Above Minimum Spec - DualShockers
New Flight Sim Wants You Broke To Get Above Minimum Spec DualShockers
National Air and Space Museum Completes Restoration of Ilyushin Il-2 Shturmovik - Vintage Aviatio...
National Air and Space Museum Completes Restoration of Ilyushin Il-2 Shturmovik Vintage Aviation News
The Interleukin-2 Market is Set to Reach USD 4 Billion by 2034, Driven by IL-2 Targeting Fusion P...
Real-time visualization of STAT activation in live cells using genetically encoded biosensors - N...
Real-time visualization of STAT activation in live cells using genetically encoded biosensors Nature
Flight sim "Korea. IL-2 series" developers dived to the ground and showed local residents - IXBT....
Flight sim "Korea. IL-2 series" developers dived to the ground and showed local residents IXBT.games
IL-2 based cancer immunotherapies: an evolving paradigm - Frontiers
IL-2 based cancer immunotherapies: an evolving paradigm Frontiers
Low-Dose Interleukin-2 Reduces Proinflammatory Biomarkers in Phase 2 Study of Alzheimer Disease -...
Low-Dose Interleukin-2 Reduces Proinflammatory Biomarkers in Phase 2 Study of Alzheimer Disease NeurologyLive
Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complicatio...
Effects of interleukin-2 in immunostimulation and immunosuppression - Rockefeller University Press
Effects of interleukin-2 in immunostimulation and immunosuppression Rockefeller University Press
Basiliximab for IL‐2‐Associated Inflammatory Disorder With Atopic Dermatitis - Becker - 2025 - Pe...
Basiliximab for IL‐2‐Associated Inflammatory Disorder With Atopic Dermatitis - Becker - 2025 - Pediatric Dermatology Wiley Online Library
Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complicatio...
Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor ...
Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor PNAS
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function - Nature
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function Nature
Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective ...
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells - Nature
Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells Nature
Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune Responses - Frontiers
Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune Responses Frontiers
Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and...
Engineering IL-2 for immunotherapy of autoimmunity and cancer - Nature
Engineering IL-2 for immunotherapy of autoimmunity and cancer Nature
Dynamically modeling the effective range of IL-2 dosage in the treatment of systemic lupus erythe...
Dynamically modeling the effective range of IL-2 dosage in the treatment of systemic lupus erythematosus ScienceDirect.com
IL-2 treatment can be dangerous. How can drug firms tackle its challenges? - Chemical & Engineeri...
IL-2 treatment can be dangerous. How can drug firms tackle its challenges? Chemical & Engineering News
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program - Nature
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program Nature
Scientists Identify Key Biomarkers That May Predict Low-Dose IL-2 Treatment Efficacy in People wi...
Scientists Identify Key Biomarkers That May Predict Low-Dose IL-2 Treatment Efficacy in People with Systemic Lupus Erythematosus Lupus Foundation of America
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy -...
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy Nature
A single-agent fusion of human IL-2 and anti-IL-2 antibody that selectively expands regulatory T ...
Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue...
Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue Nature
Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulator...
A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in...
A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia Science | AAAS
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease - NEJM Evidence
Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease NEJM Evidence
An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism - Nature
An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism Nature
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8 - Nature
A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8 Nature
An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer - Nature
An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer Nature
Regulatory T cells control toxicity in a humanized model of IL-2 therapy - Nature
Regulatory T cells control toxicity in a humanized model of IL-2 therapy Nature
Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulatio...
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases - Frontiers
Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases Frontiers
Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2 - Na...
Measurement of IFN-γ and IL-2 for the assessment of the cellular immunity against SARS-CoV-2 Nature
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes - Sci...
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes Science | AAAS
De novo design of potent and selective mimics of IL-2 and IL-15 - Nature
De novo design of potent and selective mimics of IL-2 and IL-15 Nature
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8 - Nature
IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8 Nature
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor ...
An engineered IL-2 partial agonist promotes CD8+ T cell stemness - Nature
An engineered IL-2 partial agonist promotes CD8+ T cell stemness Nature
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist...
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist Nature
Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helpe...
Differential IL-2 expression defines developmental fates of follicular versus nonfollicular helper T cells Science | AAAS
Biased IL-2 signals induce Foxp3-rich pulmonary lymphoid structures and facilitate long-term lung...
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo ...
Restoring IL-2 to its cancer immunotherapy glory - Nature
Revealing the significance of IL-2 and IL-5 in SARS-CoV-2-specific T-cell responses in kidney tra...
The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity ...
The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity Wiley Online Library
Molecular reshaping of phage-displayed Interleukin-2 at beta chain receptor interface to obtain p...
Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of ...
WW2 Flight Sim Il-2 Sturmovik Announces Final Expansion Before New Korea Game - DualShockers
WW2 Flight Sim Il-2 Sturmovik Announces Final Expansion Before New Korea Game DualShockers
T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes - Nature
T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes Nature
Why measure soluble interleukin-2 receptor levels? - News-Medical
Why measure soluble interleukin-2 receptor levels? News-Medical
Overcoming toxicities: are IL-2 smart cytokines the next big thing? - Labiotech.eu
Overcoming toxicities: are IL-2 smart cytokines the next big thing? Labiotech.eu
A promising option for unremitting ulcerative colitis: Low-dose IL-2 - Boston Children's Answers
A promising option for unremitting ulcerative colitis: Low-dose IL-2 Boston Children's Answers
T cells during infection requires MRTF/SRF-dependent gene expression and cytoskeletal dynamics - ...
T cells during infection requires MRTF/SRF-dependent gene expression and cytoskeletal dynamics Nature
Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity - Nature
Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity Nature